Back to 
Nuveen, LLC
Nuveen, LLC
HBIO
2 quarters
Position history for Nuveen, LLC's holdings in Harvard Bioscience, Inc.
No. Nuveen exited its HBIO (Harvard Bioscience) position in Q2 2025. Its Q1 2025 13F listed 139,999 shares worth $79,239. Nuveen already held HBIO in its Q1 2025 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$79,239
Total Shares Change
-139,999
Quarter-by-Quarter History